Completed
Efficacy and Immunogenicity Study of Recombinant Human Papillomavirus Bivalent(Type 16/18 )Vaccine
NCT01735006
- Conditions
- Cervical Cancer, Cervical Intraepithelial Neoplasia, Disease Attributes, +21 more
- Locations
-
- Cancer Institute & Hospital Chinese Academy of Medical Sciences Beijing, China